军人粗大的内捧猛烈进出视频 ,无码内射中文字幕岛国片,亚洲精品乱码久久久久久久久久久久,欧美日韩国产精品自在自线

<small id="i6gmr"><tbody id="i6gmr"><noframes id="i6gmr"></noframes></tbody></small>

NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing

Continue to promote high-quality products and services to a new level

2025-05-26

Learn more +
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing

Another quick approval

2025-05-22

Learn more +
Paclitaxel For Injection (Albumin Bound) approved by US FDA

2025-05-20

Learn more +
King-Friend will meet you in CPHI Frankfurt!

Explore the infinite boundaries of the pharmaceutical market！

2025-05-19

Learn more +
King-Friend will meet you in CPHI Shanghai!

Explore the infinite possibilities of the pharmaceutical industry！

2025-05-13

Learn more +
NKF's Liraglutide Injection gets FDA approval for marketing

Benefiting more patients around the world.

2025-04-04

Learn more +
NKF's Rocuronium Bromide Injection getting approved by NMPA

Bring new hope for health to thousands of patients.

2025-03-01

Learn more +
NKF's Fulvestrant Injection getting approved by NMPA

Help to enhance treatment experience and health well-being.

2025-02-11

Learn more +
NKF's Methylene Blue Injection gets FDA approval for marketing

Let every medication be a solemn commitment to life.

2025-01-25

Learn more +

1
2

Stock price

11.260

-0.23

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.LtdSu ICP Bei No. 13012010

<i id="7wer3"><ins id="7wer3"></ins></i>